FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to the pharmaceutical industry, namely, to a composition for maintaining the normal state of homeostasis and to a medicinal product based thereon. Composition for maintaining the normal state of homeostasis contains a water-soluble protein fraction extracted from products of a destroyed pathogen of the disease whereto homeostasis is maintained, with a molecular weight of 6 to 90 kDa, and a phosphate-saline buffer solution, with a certain ratio of components. Medicinal product for maintaining the normal state of homeostasis contains a water-soluble protein fraction with a molecular weight of 6 to 90 kDa extracted from products of a destroyed pathogen of the disease whereto homeostasis is maintained, a phosphate-saline buffer solution, and a saline solution of formic aldehyde in a 0.00018 to 0.06% concentration, with a certain ratio of components.
EFFECT: above group allows the normal state of homeostasis to be maintained.
5 cl, 25 dwg, 11 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEANS FOR CATTLE LEUKEMIA PREVENTION AND METHOD FOR ITS APPLICATION | 2016 |
|
RU2631607C1 |
| AGENT FOR THE TREATMENT OF RADIATION SICKNESS | 2022 |
|
RU2797586C1 |
| INJECTION MEDICINAL AGENT AGAINST HUMAN CANDIDOSIS | 2005 |
|
RU2281110C1 |
| MEDICINE FOR THE TREATMENT OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES | 2020 |
|
RU2790663C1 |
| AGENT FOR TREATING CORONAVIRUS, RETROVIRUS INFECTIONS AND HEPATITIS C | 2020 |
|
RU2738719C1 |
| AGENT FOR DIAGNOSTICS OF BOVINE LEUKAEMIA AND METHOD OF ITS APPLICATION | 2014 |
|
RU2560684C1 |
| MITOCHONDRIAL DYSFUNCTION CORRECTION AGENT | 2021 |
|
RU2765467C1 |
| REPRODUCTIVE FUNCTION ENHANCER | 2019 |
|
RU2728709C1 |
| ANTIVIRAL DRUG FOR INJECTION | 2022 |
|
RU2794098C1 |
| BIOLOGICALLY ACTIVE REMEDY, METHOD FOR ITS PRODUCING, PREPARATION CONTAINING THE MENTIONED REMEDY AND METHOD FOR APPLYING THE PREPARATION | 1992 |
|
RU2041715C1 |
